{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:19Z","timestamp":1790386399640,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jaci.2019.08.035","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T08:22:10Z","timestamp":1570609330000},"page":"1478-1489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Frontiers in alopecia areata pathobiology research"],"prefix":"10.1016","volume":"144","author":[{"given":"Amos","family":"Gilhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimma","family":"Laufer-Britva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviad","family":"Keren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.08.035_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.08.035_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/exd.12209","article-title":"What causes alopecia areata?","volume":"22","author":"McElwee","year":"2013","journal-title":"Exp Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.08.035_bib3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jaad.2018.12.051","article-title":"Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: a prospective, cross-sectional study","volume":"80","author":"Putterman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","article-title":"Comorbidities in alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib6","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jaad.2018.08.059","article-title":"Rethinking the classification of alopecia areata","volume":"80","author":"Wambier","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib7","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"16","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2019.08.035_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT-cells ameliorate human autoimmunity: lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J Autoimmun"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.08.035_bib9","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jid.2019.03.592","article-title":"Possible role of ILC1 in the pathogenesis of alopecia areata (AA)","volume":"139","author":"Laufer Britva","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.08.035_bib10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jid.2016.02.076","article-title":"R. \u03b3\u03b4 T-cells as novel players in alopecia areata pathobiology: V\u03b41+ T lymphocytes may recognize \u201cstressed\u201d hair follicle keratinocytes, leading to IFN\u03b3-dependent hair follicle dystrophy and immune privilege collapse","volume":"136","author":"Uchida","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nature05165","article-title":"Immunology: protection and privilege","volume":"442","author":"Waldmann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.08.035_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T-cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.08.035_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12710","article-title":"The roles of the PD-1\/PD-L1 pathway at immunologically privileged sites","volume":"78","author":"Wang","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model","volume":"64","author":"Ito","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.08.035_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1087-0024.2003.00807.x","article-title":"The hair follicle and immune privilege","volume":"8","author":"Paus","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","article-title":"A 'hairy' privilege","volume":"26","author":"Paus","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3892\/ijmm.2016.2547","article-title":"Differential effects of the two amino acid sensing systems, the GCN2 kinase and the mTOR complex 1, on primary human alloreactive CD4\u207a T-cells","volume":"37","author":"Eleftheriadis","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaci.2019.08.035_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cmet.2017.01.014","article-title":"Serine\u00a0is an essential metabolite for effector T-cell expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2019.08.035_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14728220903018940","article-title":"Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases","volume":"13","author":"Tan","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2019.08.035_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fimmu.2016.00037","article-title":"Ocular immune privilege and transplantation","volume":"7","author":"Taylor","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2133.1994.tb08488.x","article-title":"Expression of classical and non-classical MHC Class I antigens in murine hair follicles","volume":"131","author":"Paus","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1523-1747.1998.00228.x","article-title":"MHC Class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in\u00a0vivo","volume":"111","author":"R\u00fcckert","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/exd.12205","article-title":"The\u00a0immune system of mouse vibrissae follicles: cellular composition and indications of immune privilege","volume":"22","author":"Bertolini","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","article-title":"The human hair follicle immune system: cellular composition and immune privilege","volume":"142","author":"Christoph","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib25","first-page":"1077","article-title":"Evidence that the bulge region is a site of relative immune privilege in human hair follicles","volume":"159","author":"Meyer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib26","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/jid.2010.180","article-title":"Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss","volume":"130","author":"Kang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2016.03.008","article-title":"Alopecia areata: animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies","volume":"15","author":"Gilhar","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2019.08.035_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/jid.2013.368","article-title":"Hair follicle\u00a0mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege","volume":"134","author":"Wang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.08.035_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jid.2015.12.003","article-title":"Laser capture microdissection reveals transcriptional abnormalities in alopecia areata before, during, and after active hair loss","volume":"136","author":"Li","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000131412","article-title":"Immune privilege and the skin","volume":"10","author":"Ito","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.jaci.2019.08.035_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.08.035_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00403-016-1652-9","article-title":"ULBP3: a marker for alopecia areata incognita","volume":"308","author":"Moftah","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib35","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC Class I expression in the anagen hair bulb?","volume":"66","author":"Paus","year":"1993","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jaci.2019.08.035_bib36","article-title":"White hair in alopecia areata: clinical forms and proposed physiopathological mechanisms","author":"Asz-Sigall","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T-cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice","volume":"117","author":"Gilhar","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/1523-1747.ep12584237","article-title":"Lymphocyte-mediated alopecia in C57BL\/6 mice following successful immunotherapy for melanoma","volume":"107","author":"Becker","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00403-006-0668-y","article-title":"Induction of cellular immunity against hair follicle melanocyte causes alopecia","volume":"298","author":"Nagai","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.jidsp.5640213","article-title":"Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo","volume":"4","author":"Smyth","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1991.tb00618.x","article-title":"Hair growth inhibition by heparin in mice: a model system for studying the modulation of epithelial cell growth by glycosaminoglycans?","volume":"124","author":"Paus","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib42","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/pr100422u","article-title":"Trichohyalin is a potential major autoantigen in human alopecia areata","volume":"9","author":"Leung","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib43","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2016.04.004","article-title":"Identification of autoantigen epitopes in alopecia areata","volume":"136","author":"Wang","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jdermsci.2013.07.014","article-title":"Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology","volume":"72","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2019.08.035_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib46","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/jid.2013.141","article-title":"Blocking potassium channels (Kv1.3): a new treatment option for alopecia areata?","volume":"133","author":"Gilhar","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib47","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/jid.2010.260","article-title":"Collapse of immune privilege in alopecia areata: coincidental or substantial?","volume":"130","author":"Gilhar","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjd.14645","article-title":"Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse","volume":"175","author":"Bertolini","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1087-0024.2003.00803.x","article-title":"Mechanisms of immune privilege in the eye and hair follicle","volume":"8","author":"Niederkorn","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/jidsymp.2015.31","article-title":"Toward the clonotype analysis of alopecia areata-specific, intralesional human CD8+ T lymphocytes","volume":"17","author":"Bertolini","year":"2015","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121949","article-title":"High-throughput T-cell receptor sequencing identifies clonally expanded CD8+ T-cell populations in alopecia areata","volume":"3","author":"de Jong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.08.035_bib52","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2353\/ajpath.2007.061206","article-title":"Probing the effects of stress mediators on the human hair follicle: substance P holds central position","volume":"171","author":"Peters","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.08.035_bib53","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/sj.jid.5700704","article-title":"Substance P as an immunomodulatory neuropeptide in a mouse model\u00a0for autoimmune hair loss (alopecia areata)","volume":"127","author":"Siebenhaar","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","article-title":"Interferon-gamma-deficient mice are resistant to the development of alopecia areata","volume":"155","author":"Freyschmidt-Paul","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13543784.2019.1568989","article-title":"New drugs under investigation for the treatment of alopecias","volume":"28","author":"Ocampo-Garza","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2019.08.035_bib56","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jaad.2018.12.041","article-title":"Tofacitinib therapy for children with severe alopecia areata","volume":"80","author":"Dai","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jaad.2018.08.040","article-title":"Ruxolitinib for the treatment of severe alopecia areata","volume":"80","author":"Liu","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib58","doi-asserted-by":"crossref","first-page":"e89776","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.08.035_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.08.035_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/clin.1993.1015","article-title":"Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma","volume":"66","author":"Gilhar","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2019.08.035_bib61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.0022-202X.2004.23580.x","article-title":"Alopecia areata induced in C3H\/HeJ mice by interferon-gamma: evidence for loss of immune privilege","volume":"124","author":"Gilhar","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jeas.2006.10.005","article-title":"Failure to induce alopecia areata in C3H\/HeJ mice with exogenous interferon gamma","volume":"43","author":"Sundberg","year":"2007","journal-title":"J Exp Anim Sci"},{"key":"10.1016\/j.jaci.2019.08.035_bib63","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1038\/s41598-018-30997-3","article-title":"Induction of alopecia areata in C3H\/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma","volume":"8","author":"Shin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.08.035_bib64","doi-asserted-by":"crossref","first-page":"33432","DOI":"10.18632\/oncotarget.16504","article-title":"SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2019.08.035_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI551","article-title":"Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice","volume":"101","author":"Gilhar","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.08.035_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archderm.138.7.916","article-title":"Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice","volume":"138","author":"Gilhar","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib67","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","article-title":"Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)\/CD25(-) cells promote systemic alopecia areata and CD4(+)\/CD25(+) cells blockade disease onset in the C3H\/HeJ mouse model","volume":"124","author":"McElwee","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib68","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.135.5.546","article-title":"Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T-cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaci.2018.02.015","article-title":"Innate lymphoid cells 3 induce psoriasis in xenotransplanted healthy human skin","volume":"142","author":"Keren","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib70","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2353\/ajpath.2010.100078","article-title":"Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways","volume":"177","author":"Guerrero-Aspizua","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.08.035_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/exd.12321","article-title":"Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies","volume":"23","author":"Bracke","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/JID.2015.362","article-title":"Differential features between chronic skin inflammatory diseases revealed in skin-humanized psoriasis and atopic dermatitis mouse models","volume":"136","author":"Carretero","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(00)00120-1","article-title":"Characterization of a T-cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system","volume":"24","author":"Nickoloff","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2019.08.035_bib74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1521-6616(02)00042-6","article-title":"Transfer of alopecia areata in the human scalp graft\/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response","volume":"106","author":"Gilhar","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cei.13189","article-title":"Skin resident memory CD8+ T-cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function","volume":"194","author":"Seidel","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib77","doi-asserted-by":"crossref","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular masT-cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"5","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.08.035_bib78","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2018.03.013","article-title":"Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology","volume":"19","author":"Rankin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.08.035_bib79","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/s41598-018-25384-x","article-title":"Pathological conversion of regulatory T-cells is associated with loss of allotolerance","volume":"8","author":"Hua","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.08.035_bib80","doi-asserted-by":"crossref","first-page":"1679197","DOI":"10.1155\/2018\/1679197","article-title":"Immune privilege and eye-derived T-regulatory cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib81","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T-cells reside in human skin","volume":"124","author":"Sanchez Rodriguez","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.08.035_bib82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1684\/ejd.2015.2709","article-title":"Characteristics of peripheral blood CD4+CD25+ regulatory T-cells and related cytokines in severe atopic dermatitis","volume":"26","author":"Zhang","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib83","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jaci.2018.11.031","article-title":"Blood endotyping distinguishes the profile of vitiligo from other inflammatory and autoimmune skin diseases","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.08.035_bib84","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jisp.2016.10.023","article-title":"Replenishing regulatory T-cells to halt depigmentation in vitiligo","volume":"18","author":"Le Poole","year":"2017","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2019.08.035_bib85","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1523-1747.2002.01745.x","article-title":"Transient CD44 variant isoform expression and reduction in CD4(+)\/CD25(+) regulatory T-cells in C3H\/HeJ mice with alopecia areata","volume":"118","author":"Z\u00f6ller","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib86","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jdv.14775","article-title":"Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients","volume":"32","author":"Loh","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2019.08.035_bib87","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T-cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdermsci.2013.01.006","article-title":"Impaired inhibitory function of circulating CD4+CD25+ regulatory T-cells in alopecia areata","volume":"70","author":"Shin","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2019.08.035_bib89","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects\u00a0of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib90","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1167\/iovs.10-7154","article-title":"Can the hair follicle become a model for studying selected aspects of human ocular immune privilege?","volume":"52","author":"Kinori","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2019.08.035_bib91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib92","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nri.2016.75","article-title":"Immunity by equilibrium","volume":"16","author":"Eberl","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib93","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2018.11.045","article-title":"Gene regulatory programs conferring phenotypic identities to human NK cells","volume":"176","author":"Collins","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.08.035_bib94","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/j.1600-0625.2010.01106.x","article-title":"An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T-cells pathogenic?","volume":"19","author":"Kaufman","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib95","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/imm.12224","article-title":"Subsets of human natural killer cells and their regulatory effects","volume":"141","author":"Fu","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2019.08.035_bib96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib97","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamadermatol.2014.62","article-title":"Diagnostic usefulness of a peribulbar eosinophilic infiltrate in alopecia areata","volume":"150","author":"Yoon","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib98","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel Th17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib99","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygeno.2011.08.009","article-title":"Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata","volume":"98","author":"Coda","year":"2011","journal-title":"Genomics"},{"key":"10.1016\/j.jaci.2019.08.035_bib101","doi-asserted-by":"crossref","first-page":"503587","DOI":"10.1155\/2010\/503587","article-title":"Serum interleukin-4 and total immunoglobulin E in nonatopic alopecia areata patients and HLA-DRB1 typing","volume":"2010","author":"Attia","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.jaci.2019.08.035_bib102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","article-title":"National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata","volume":"61","author":"Barahmani","year":"2009","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib103","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib104","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00403-015-1539-1","article-title":"Lesional infiltration of mast cells, Langerhans cells, T-cells and local cytokine profiles in alopecia areata","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib106","first-page":"110","article-title":"Studies on etiology of alopecia areata. II. From a constitutional or dispositional standpoint","volume":"60","author":"Ikeda","year":"1965","journal-title":"Hifuka Kiyo"},{"key":"10.1016\/j.jaci.2019.08.035_bib107","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18008","article-title":"Alopecia areata is characterised by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","author":"Bain","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib109","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Su\u00e1rez-Fari\u00f1as","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/all.13346","article-title":"Alopecia\u00a0areata is characterized by expansion of circulating Th2\/Tc2\/Th22, within the skin-homing and systemic T-cell populations","volume":"73","author":"Czarnowicki","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.08.035_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/ijt.ijt_80_18","article-title":"Serum interleukin-15 is a marker of alopecia areata severity","volume":"11","author":"Ebrahim","year":"2019","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaci.2019.08.035_bib112","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib113","article-title":"Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata","author":"Gong","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib114","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.12273","article-title":"Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata","volume":"40","author":"Inui","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/ijt.ijt_62_18","article-title":"A comment on JAK inhibitors for treatment of alopecia areata","volume":"10","author":"Tr\u00fceb","year":"2018","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaci.2019.08.035_bib116","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jid.2018.05.027","article-title":"JAK Inhibitors for treatment of alopecia areata","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib117","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/jid.2009.25","article-title":"Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis","volume":"129","author":"Boy","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib118","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","article-title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of\u00a0psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study","volume":"167","author":"Papp","year":"2012","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.12266","article-title":"A\u00a0randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","volume":"169","author":"Ports","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib120","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bjd.12517","article-title":"Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment","volume":"169","author":"Strober","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib121","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","article-title":"Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis","volume":"67","author":"Punwani","year":"2012","journal-title":"J Am\u00a0Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib122","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2017.10.028","article-title":"Novel therapies for alopecia areata: the era of rational drug development","volume":"141","author":"Wang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib123","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2015-208371","article-title":"Blocking interferon \u03b3 reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex\u00a0vivo cultured arteries from patients with gianT-cell arteritis","volume":"75","author":"Corbera-Bellalta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.08.035_bib124","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40262-016-0501-5","article-title":"Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders","volume":"56","author":"Minder","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaci.2019.08.035_bib125","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1124\/jpet.107.124958","article-title":"Neurokinin 1 receptor antagonists: correlation between in\u00a0vitro receptor\u00a0interaction and in\u00a0vivo efficacy","volume":"322","author":"Lindstr\u00f6m","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2019.08.035_bib126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","article-title":"CXCR3, CXCL10 and type 1 diabetes","volume":"25","author":"Antonelli","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2019.08.035_bib127","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1111\/jdv.13879","article-title":"Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis","volume":"31","author":"Kanameishi","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2019.08.035_bib128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib129","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI71951","article-title":"CXCL11-dependent induction of FOXP3-negative regulatory T-cells suppresses autoimmune encephalomyelitis","volume":"124","author":"Zohar","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.08.035_bib130","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2018.2976","article-title":"Hair regrowth in a patient with long-standing alopecia totalis and atopic dermatitis treated with dupilumab","volume":"154","author":"Penzi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib131","first-page":"534","article-title":"Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata","volume":"179","author":"Darrigade","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib132","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdcr.2018.11.007","article-title":"Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab","volume":"5","author":"Smogorzewski","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2019.08.035_bib133","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib134","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdcr.2017.11.020","article-title":"Alopecia areata after dupilumab for atopic dermatitis","volume":"4","author":"Mitchell","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2019.08.035_bib135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/DER.0000000000000458","article-title":"Alopecia areata after treatment with dupilumab","volume":"30","author":"Yazdanyar","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaci.2019.08.035_bib136","doi-asserted-by":"crossref","first-page":"420","DOI":"10.18176\/jiaci.0301","article-title":"Alopecia areata in severe atopic dermatitis treated with dupilumab","volume":"28","author":"Barroso-Garc\u00eda","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib137","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/pde.13699","article-title":"Response to ustekinumab in three pediatric patients with alopecia areata","volume":"36","author":"Aleisa","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib138","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00403-018-1876-y","article-title":"A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata","volume":"311","author":"Mikhaylov","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2019.08.035_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18264","article-title":"Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata","author":"Laufer Britva","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib141","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2019.08.035_bib142","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/exd.13123","article-title":"Genome-wide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2","volume":"26","author":"Fischer","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.08.035_bib143","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14728222.2018.1481504","article-title":"Alopecia areata and the gut-the link opens up for novel therapeutic interventions","volume":"22","author":"Borde","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2019.08.035_bib144","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib145","first-page":"369","article-title":"Invariant NKT-cells produce IL-17 through IL-23-dependent and independent pathways with potential modulation of Th17 response in collagen-induced arthritis","volume":"22","author":"Yoshiga","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaci.2019.08.035_bib146","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The\u00a0burgeoning\u00a0family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.08.035_bib147","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fimmu.2015.00118","article-title":"A highly focused antigen receptor repertoire characterizes \u03b3\u03b4 T-cells that are poised to make IL-17 rapidly in naive animals","volume":"6","author":"Wei","year":"2015","journal-title":"Front Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919311820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919311820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:23:17Z","timestamp":1758792197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919311820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0091674919311820"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.08.035","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frontiers in alopecia areata pathobiology research","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}